Ticker
HBIOCompany Name
HARVARD BIOSCIENCE INCSector
HealthcareIndustry
Medical Instruments & SuppliesExchange
NASDAQ| Date | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
|---|---|---|---|
| 6/30/2025 | $ 4.13M | 19.37% | $ 21.33M |
| 3/31/2025 | $ -203K | -1.3% | $ 15.56M |
| 12/31/2024 | $ -1.82M | -6.38% | $ 28.56M |
| 9/30/2024 | $ -132K | -0.12% | $ 112.09M |
| 6/30/2024 | $ 5.96M | 4.38% | $ 136.07M |
| 3/31/2024 | $ 10.81M | 6.64% | $ 162.86M |
| 12/31/2023 | $ 11.72M | 5.99% | $ 195.73M |
| 9/30/2023 | $ 11.21M | 6.18% | $ 181.43M |
| 6/30/2023 | $ 7.27M | 3.85% | $ 189.11M |
| 3/31/2023 | $ 3.61M | 1.53% | $ 235.84M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield FCF Yield for HARVARD BIOSCIENCE INC is calculated as follows: FCF [ $ 7.54M ] / Market Cap [ $ 143.04M ]
(=) FCF Yield [ 5.27% ] Minimum
Dec 31, 2024
Maximum
Jun 30, 2025
Average
Median
| filtered constituents | 3.58K |
|---|---|
| min | -33.87% |
| max | 37.55% |
| average | 1.59% |
| median | 3.22% |
| std | 11.38% |